Diabetes and Endocrinology

20 percent greater mortality benefit seen in obstructive sleep apnea population

Patients prescribed SGLT2 inhibitors less likely to exhibit nodule growth and to undergo a surgical intervention

GONAL-F helps stimulate ovulation and will soon be available at a discount through TrumpRx, a federal website set to launch in 2026

The new CalRx insulin will work as a generic version of glargine and could save patients $2,000 to $4,000 per year

Prevalence increased to 68.6 percent with new criteria, which include anthropometric measures such as waist circumference, waist-to-hip ratio, waist-to-height ratio

Authors say findings underscore the importance of improving muscle mass and strength in at-risk people

New ICD-10 diagnosis code is for patients with history of type 2 diabetes who bring blood sugar levels to a non-diabetic range below 6.5% for at least three months

Even higher use seen in patients without type 2 diabetes

Rates of attrition up for male and female physicians, in rural and urban settings, across specialties, across geographic regions

Authors say in those without diabetes, continuous glucose monitors are not a substitute for HbA1c